ZURICH (Reuters) - Swiss specialty chemicals maker Clariant (S:CLN) said on Thursday it expected North America to become its second-largest market with sales of about $2 billion by 2021.
Key elements in this growth strategy include advancing its research and development competencies, a CAPEX investment of $250 million to further increase both its manufacturing footprint and technical capabilities, and the leveraging of shale gas opportunities, Clariant said in a statement.
Clariant has over 50 sites and more than 2,400 employees in the U.S. and Canada and currently generates a turnover of around $1.25 billion in the region, it said.